Emergency Executive Order No. 587, is being submitted to extend Emergency Executive Order No. 585, dated April 24, 2024 for five (5) days if this relates to Rikers.
Emergency Executive Order No. 585 is being submitted to extend Emergency Executive Order No. 583, dated April 19, 2024 for five (5) days, if this relates to Rikers.
The Mayor’s Office Diversity, Equity, Inclusion and Equal Employment Opportunity (DEI-EEO) Plan for Fiscal Year 2024 establishes, and measures programs, initiatives, and trainings tailored to the agency’s mission, operations, and workforce. (Uploaded after GPP site technical issues were resolved.)
A quarterly report on EDC’s expenditure, as well as, retention or designation of persons or organizations to engage in lobbying or lobbying activities before the council or any member thereof, the city planning commission, a borough president, a borough board or a community board.
Emergency Executive Order No. 583 is being submitted to extend Emergency Executive Order No. 581, dated April 14, 2024 for five (5) days, if this relates to Rikers.
Emergency Executive Order No. 581, is being submitted to extend Emergency Executive Order No. 579, dated April 9, 2024 for five (5) days if this relates to Rikers.
Project description required to be submitted to the speaker where the project receives financial assistance but the project is not required to be submitted for consideration to a Community Board, Borough Board or the City Council.
Emergency Executive Order No. 579, is being submitted to extend Emergency Executive Order No. 577, dated March 25, 2024 for five (5) days, if this relates to Rikers.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.